From the Guidelines
9 units of Humulin M3 is within the possible initial dose range for some patients, but insulin dosing is highly individualized and should be adjusted based on blood glucose monitoring results. Insulin requirements depend on many factors including body weight, insulin sensitivity, carbohydrate intake, physical activity level, and other medical conditions 1. Humulin M3 is a premixed insulin containing 30% soluble insulin (rapid-acting) and 70% isophane insulin (intermediate-acting).
Key Considerations
- Dosing typically starts low and is gradually adjusted based on blood glucose monitoring results.
- Initial doses often range from 4-20 units, with adjustments made in small increments (1-2 units) every few days until target blood glucose levels are achieved, as suggested by the American Diabetes Association standards of medical care in diabetes 1.
- Patients should never adjust their insulin dose without medical supervision, as incorrect dosing can lead to dangerous high or low blood sugar levels.
Important Factors
- Regular blood glucose monitoring is essential when using insulin, and patients should be familiar with hypoglycemia symptoms and treatment.
- A safe and simple approach is to prescribe 10 units, or 0.1 to 0.2 units/kg of body weight, of basal insulin per day and advise to increase the dose by 10% to 15%, or 2 to 4 units, once or twice weekly until the fasting blood glucose target is met, as recommended in the 2017 American Diabetes Association standards of medical care in diabetes 1.
Clinical Decision Making
- The decision to use 9 units of Humulin M3 should be based on individual patient factors and medical history, and should be made in consultation with a healthcare provider.
- The healthcare provider should consider the patient's body weight, insulin sensitivity, carbohydrate intake, physical activity level, and other medical conditions when determining the appropriate dose of Humulin M3.
From the Research
Humulin M3 Dosage
- The provided studies do not specifically address the normal dosage of Humulin M3, which is a type of human insulin.
- The studies focus on the use of continuous glucose monitoring (CGM) technology, artificial intelligence, and self-monitoring of blood glucose in managing diabetes, rather than insulin dosages 2, 3, 4, 5.
- One study discusses the importance of structured self-monitoring of blood glucose in achieving glycaemic control in non-insulin treated Type 2 diabetes, but does not provide information on insulin dosages 6.
- There is no direct evidence in the provided studies to determine if 9 units of Humulin M3 is a normal dose, as this information is not addressed in the studies 2, 3, 4, 5, 6.
Insulin Therapy
- Insulin therapy, including the use of Humulin M3, is a common treatment for diabetes, but the dosage depends on individual factors such as blood glucose levels, diet, and physical activity.
- The studies highlight the importance of monitoring blood glucose levels and adjusting treatment plans accordingly, but do not provide specific guidance on Humulin M3 dosages 2, 4, 6.
- Further research or consultation with a healthcare professional would be necessary to determine the appropriate dosage of Humulin M3 for a specific individual 2, 3, 4, 5, 6.